These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 413793)

  • 1. Beta lactamase resistance of newer cephalosporins and antimicrobial effectiveness against gram-negative bacilli.
    Farrar WE; O'Dell NM
    Infection; 1977; 5(4):224-7. PubMed ID: 413793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activity of cephalosporins on beta-lactamase-producing Neisseria gonorrhoeae.
    Phillips I; Shannon K
    Scand J Infect Dis Suppl; 1978; (13):23-6. PubMed ID: 98833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative activity of two newer cephalosporins, cefoxitin, and cephalothin against selected Enterobacteriaceae and correlation with enzymatic resistance mechanisms.
    Vuye A; Pijck J; Van Landuyt HW
    J Antimicrob Chemother; 1979 May; 5(3):293-300. PubMed ID: 314440
    [No Abstract]   [Full Text] [Related]  

  • 4. [Microbiological evaluation of cefoxitin, a new beta-lactamase resistant cephamycin antibiotic, compared to cephalothin, cephaloridine and cefazolin].
    Schassan HH; Bentfeld G
    Fortschr Med; 1978 Aug; 96(30):1510-7. PubMed ID: 669547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial evaluation of cefoxitin: a new semisynthetic cephamycin. Comparative studies with cefazolin and cefalotin.
    Une T; Mitsuhashi S
    Arzneimittelforschung; 1977; 27(1):89-93. PubMed ID: 576821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamases.
    Sanders CC; Sanders WE
    Antimicrob Agents Chemother; 1979 Jun; 15(6):792-7. PubMed ID: 314270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vitro spectrum of the cephalosporins.
    Washington JA
    Mayo Clin Proc; 1976 Apr; 51(4):237-50. PubMed ID: 1263595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antistaphylococcal activity and beta-lactamase resistance of newer cephalosporins.
    Farrar WE; Gramling PK
    J Infect Dis; 1976 Jun; 133(6):691-5. PubMed ID: 1047087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newer cephalosporins and cephamycins--a review.
    Norrby R
    Scand J Infect Dis Suppl; 1978; (13):83-7. PubMed ID: 356183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the antibacterial activity of nine cephalosporins against Enterobacteriaceae and nonfermentative gram-negative bacilli.
    Verbist L
    Antimicrob Agents Chemother; 1976 Oct; 10(4):657-63. PubMed ID: 984801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of cephalosporin resistance in clinical isolates of Escherichia coli.
    Sawai T; Ando-Kuroda I; Murata T; Yamagishi S
    J Pharmacobiodyn; 1980 Jul; 3(7):364-6. PubMed ID: 7009827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of correlation between beta-lactamase production and susceptibility to cefamandole or cefoxitin among spontaneous mutants of Enterobacteriaceae.
    Ott JL; Turner JR; Mahoney DF
    Antimicrob Agents Chemother; 1979 Jan; 15(1):14-9. PubMed ID: 311615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanism.
    Then RL; Angehrn P
    Antimicrob Agents Chemother; 1982 May; 21(5):711-7. PubMed ID: 6808912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics.
    George WL; Lewis RP; Meyer RD
    Antimicrob Agents Chemother; 1978 Mar; 13(3):484-9. PubMed ID: 122524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory concentrations of cefoperazone, cefazolin, cefamandole, cephaloridine, and cefoxitin for 300 gram-negative clinical isolates.
    Trabulsi LR; Pereira da Silva Almada N; Marques LR
    Clin Ther; 1980; 3(Spec Issue):145-8. PubMed ID: 6446390
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation of in vitro susceptibility with in vivo efficacy in mice for cefoxitin in comparison with cephalosporins.
    Miller AK; Celozzi E; Pelak BA; Birnbaum J; Stapley EO
    J Antimicrob Chemother; 1979 Sep; 5(5):569-79. PubMed ID: 315403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-lactamase resistance of cephazolin and other cephalosporins.
    Goodwin CS; Hill JP
    Scott Med J; 1976 Sep; 20(5):236-9. PubMed ID: 772808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of seven cephalosporins: susceptibility to beta-lactamases and ability to penetrate the surface layers of Escherichia coli.
    Richmond MH; Wotton S
    Antimicrob Agents Chemother; 1976 Aug; 10(2):219-22. PubMed ID: 791093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro testing of newer cephalosporins (author's transl)].
    Linzenmeier G; Rosenthal E
    Infection; 1979; 7 Suppl 2():S225-7. PubMed ID: 437897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of drug resistance. The beta-lactamases of gram-negative bacteria including pseudomonads.
    Richmond MH; Jack GW; Sykes RB
    Ann N Y Acad Sci; 1971 Jun; 182():243-57. PubMed ID: 4998885
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.